查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087778

傷口生物製劑市場：2026-2032年全球市場預測（依產品類型、應用、最終用戶及通路分類）

Wound Biologics Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，傷口生物製劑市場將成長至 38.7 億美元，複合年成長率為 9.12%。

主要市場統計數據
基準年 2025 21億美元
預計年份：2026年 22.8億美元
預測年份 2032 38.7億美元
複合年成長率 (%) 9.12%

傷口生物製劑市場執行摘要

傷口生物製劑產品正在重新定義高級傷口護理的概念，它們利用活細胞、細胞外基質、膠原蛋白、生長因子、胎盤衍生組織和生物工程創傷護理替代物，支持複雜急性和慢性傷口的組織修復。這種需求與糖尿病、血管疾病、燒傷、手術傷口和壓瘡等疾病負擔的日益惡化密切相關。根據國際糖尿病聯盟（IDF）統計，2021年全球有5.37億成年人患有糖尿病，預計2030年將達到6.43億人。這進一步增加了臨床上對能夠改善傷口癒合效果的解決方案的需求。

傷口生物製劑領域的變革性變化

傷口生物製劑領域正從被動覆蓋轉向主動組織再生。臨床醫生正在使用能夠促進血管生成、基質重塑和細胞遷移的產品，尤其適用於糖尿病足潰瘍、下肢靜脈潰瘍、壓瘡、燒傷和難以癒合的手術傷口。這項轉變得益於先進的傷口評估、標準化清創方案、減輕負重、壓迫療法和感染控制等措施的日益普及。

人工智慧在傷口生物製劑領域的累積影響

人工智慧 (AI) 正開始對傷口生物製劑領域產生深遠影響，從藥物研發和臨床決策支援到商業化，沒有例外。 AI 影像分析技術能夠透過一系列照片估算傷口大小、組織成分、滲出液量和癒合進展，從而提高記錄的準確性並減少主觀差異。這些工具在傷口診所和居家醫療機構中變得越來越重要，因為在這些機構中，持續的評估對於保險報銷和護理協調至關重要。

傷口生物製劑的關鍵區域性見解

北美地區仍然是關鍵區域，這得益於其高糖尿病盛行率、完善的創傷護理中心以及先進的皮膚替代品和細胞/組織衍生產品的成熟報銷機制。尤其值得一提的是，美國具有舉足輕重的影響力，因為其保險公司的福利決策和臨床證據標準往往會影響全球商業化策略。加拿大則憑藉其結構良好的省級醫療保健體係以及日益普及的循證慢性傷口治療方案，為該領域做出了貢獻。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

在東協地區，醫院基礎設施的擴建、醫療旅遊的發展以及新加坡、馬來西亞、泰國、印尼和越南等國糖尿病護理需求的不斷成長，是推動該地區成長的主要動力。在海灣合作理事會（GCC）國家，由於糖尿病盛行率高、私人醫療保健體系健全以及對專科醫院的投資，對高品質創傷護理技術的需求旺盛。在歐盟，監管協調、臨床文件和成本效益備受重視，市場准入需要強力的證據、上市後監測以及遵守不斷發展的醫療設備和組織相關框架。

主要國家傷口生物製劑的發展趨勢

美國是最大的策略市場，其促進因素包括慢性傷口負擔沉重、專業的門診傷口護理中心以及保險公司對皮膚替代品使用的嚴格審查。在加拿大，省級醫療保健系統優先考慮循證應用；而在墨西哥和巴西，公共和私人醫療保健投資、糖尿病項目以及更強大的醫院網路正在擴大皮膚替代品的普及範圍。在歐洲，英國、德國、法國、義大利和西班牙關注臨床價值、醫院採購規範、醫療技術評估以及創傷護理的需求；而在俄羅斯，需求則受到國內醫療資源取得、報銷制度差異和採購限制的影響。

為行業領導者提供的實用建議

產業領導者應優先考慮能夠證明生物製劑能夠加速傷口癒合、維持傷口縫合、減少併發症並降低總治療成本的臨床證據。基於隨機對照試驗、真實世界數據和註冊登記的研究結果應與支付方對糖尿病足潰瘍、靜脈性下肢潰瘍、壓瘡、燒傷和手術傷口的要求相一致。企業還應投資於醫療專業人員的培訓，使其能夠將生物製藥與清創術、感染控制、減輕負重、壓迫療法、血管評估、營養管理和血糖控制相結合。

調查方法

本調查方法結合了二手資料研究、專家檢驗和資料檢驗。資訊來源包括監管文件、臨床指南、醫院採購指標、同行評審的創傷護理文獻、報銷政策、公共衛生資料集以及來自世界衛生組織、美國疾病管制與預防中心、國際糖尿病聯盟、美國食品藥物管理局、歐洲藥品管理局和國家衛生機構等權威機構的疾病負擔統計數據。

結論

傷口生物製劑正從高級創傷護理的小眾領域轉變為再生醫學和慢性傷口管理的核心要素。臨床證物、健保報銷機制和專科診療路徑的整合將帶來最大的發展機會。糖尿病、人口老化、手術複雜性的增加、燒傷、血管疾病以及壓瘡預防等問題將繼續推動市場需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 傷口生物製劑市場：依產品類型分類

  • 膠原蛋白
    • 牛膠原蛋白
    • 馬源膠原膠原蛋白
    • 豬源膠原膠原蛋白
  • 生長因子
    • 表皮生長因子
    • 纖維母細胞生長因子
    • 血小板衍生生長因子
    • 血管內皮生長因子
  • 血小板衍生製劑
    • 血小板濃縮纖維蛋白
    • 富血小板血漿
  • 皮膚替代材料
    • 生物來源真皮
    • 複合真皮
    • 合成真皮

第8章 傷口生物製劑市場：依應用領域分類

  • 急性傷口
  • 燒傷
    • 二度燒傷
    • 三度燒傷
  • 慢性傷口
    • 糖尿病足潰瘍
    • 壓瘡
    • 下肢靜脈潰瘍
  • 外科性創傷

第9章 傷口生物製劑市場：依最終使用者分類

  • 門診手術中心
  • 居家照護
  • 醫院
  • 創傷護理中心

第10章 傷口生物製劑市場：依通路分類

  • 離線
  • 線上

第11章 傷口生物製劑市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 傷口生物製劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 傷口生物製劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Acera Surgical, Inc.
  • Alliqua BioMedical, Inc.
  • Amnio Technology, LLC
  • Anika Therapeutics, Inc.
  • Aroa Biosurgery Limited
  • Avita Medical, Inc.
  • Aziyo Biologics, Inc.
  • BioTissue, Inc.
  • CollPlant Biotechnologies Ltd.
  • Coloplast A/S
  • Convatec Group Plc
  • Fibroheal Woundcare Pvt Ltd
  • Human BioSciences, Inc.
  • Imbed Biosciences Inc.
  • Integra LifeSciences Corporation
  • Marine Polymer Technologies, Inc.
  • MiMedx Group, Inc.
  • MTF Biologics
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • Polynovo Limited
  • RenovaCare, Inc.
  • Skye Biologics, Inc.
  • Smith & Nephew plc
  • Solsys Medical LLC
  • Tides Medical
  • Vericel Corporation
  • VIVEX Biologics, Inc.
Product Code: MRR-0315DDADCE4B

The Wound Biologics Market is projected to grow by USD 3.87 billion at a CAGR of 9.12% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.10 billion
Estimated Year [2026] USD 2.28 billion
Forecast Year [2032] USD 3.87 billion
CAGR (%) 9.12%

Wound Biologics Market Executive Summary

Wound biologics are redefining advanced wound care by using living cells, extracellular matrices, collagen, growth factors, placental-derived tissues, and bioengineered skin substitutes to support tissue repair in complex acute and chronic wounds. Demand is closely tied to the rising burden of diabetes, vascular disease, burns, surgical wounds, and pressure injuries. The International Diabetes Federation reported 537 million adults living with diabetes in 2021, with projections reaching 643 million by 2030, reinforcing the clinical need for solutions that improve healing outcomes.

Market momentum is strongest where evidence-based reimbursement, specialist wound centers, and multidisciplinary care pathways are established. Hospitals, ambulatory wound clinics, and home-care networks are increasingly evaluating biologic wound dressings and skin substitutes based on healing rates, time to closure, recurrence reduction, infection control, and total cost of care rather than product price alone.

Transformative Shifts in the Wound Biologics Landscape

The wound biologics landscape is shifting from passive coverage to active tissue regeneration. Clinicians are adopting products that support angiogenesis, matrix remodeling, and cellular migration, especially for diabetic foot ulcers, venous leg ulcers, pressure injuries, burns, and difficult surgical wounds. This transition is supported by growing use of advanced wound assessment, standardized debridement protocols, offloading, compression therapy, and infection management.

Commercial transformation is also being shaped by stricter evidence expectations. Payers and regulators are emphasizing randomized clinical evidence, real-world outcomes, traceability, donor screening, and manufacturing consistency. As a result, industry participants are investing in differentiated biologic platforms, stronger clinical dossiers, and education programs that help providers select the right biologic intervention at the right stage of healing.

Cumulative Impact of Artificial Intelligence on Wound Biologics

Artificial intelligence is beginning to influence wound biologics across discovery, clinical decision support, and commercialization. AI-enabled imaging can help estimate wound dimensions, tissue composition, exudate levels, and healing trajectory from serial photographs, improving documentation and reducing subjective variation. These tools are increasingly relevant in wound clinics and home-health settings where consistent assessment is essential for reimbursement and care coordination.

The cumulative impact of AI will be strongest when imaging, electronic health records, product utilization data, and outcomes registries are combined. Predictive models can support patient stratification, identify non-healing wounds earlier, and guide biologic product selection. In manufacturing and quality systems, AI can improve process monitoring, batch analytics, supply planning, and adverse event signal detection while maintaining compliance with medical device, biologic, and tissue regulations.

Key Regional Insights for Wound Biologics

North America remains a leading region due to high diabetes prevalence, established wound care centers, and reimbursement pathways for advanced skin substitutes and cellular or tissue-based products. The United States is especially influential because payer coverage decisions and clinical evidence standards often shape global commercialization strategies. Canada contributes through structured provincial healthcare systems and growing adoption of evidence-based chronic wound protocols.

Europe demonstrates steady demand supported by aging populations, hospital wound programs, and regulatory emphasis under the Medical Device Regulation and tissue standards. Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia address diabetes, surgical volume, and elderly care needs. IDF data show that China and India have among the world's largest diabetes populations, while Japan and South Korea face advanced aging profiles that increase chronic wound and post-surgical care requirements.

Latin America is advancing selectively, led by Brazil and Mexico through public-private healthcare investment, specialized hospital networks, and a growing focus on diabetic foot ulcer prevention. The Middle East shows uptake in high-income health systems where diabetes prevalence, burn care capacity, and specialty hospital investment support premium advanced wound care. Africa remains more access-sensitive, with demand linked to trauma, burns, infection management, diabetes detection, and gradual expansion of specialist wound services.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, growth is supported by expanding hospital infrastructure, medical tourism, and increasing diabetes care needs in countries such as Singapore, Malaysia, Thailand, Indonesia, and Vietnam. The GCC shows demand for premium wound care technologies due to high diabetes prevalence, strong private healthcare systems, and investment in specialty hospitals. The European Union emphasizes regulatory harmonization, clinical documentation, and cost-effectiveness, making market access dependent on robust evidence, post-market surveillance, and compliance with evolving medical device and tissue frameworks.

BRICS countries represent significant long-term opportunity because of large patient populations, expanding insurance coverage, increasing surgical capacity, and growing domestic manufacturing capabilities. G7 markets remain central for innovation, reimbursement benchmarks, health technology assessment, clinical guideline development, and adoption of advanced biologic wound dressings. NATO countries overlap with many high-income wound care markets and also maintain demand for trauma, burn, and surgical wound solutions within civilian and defense healthcare systems, reinforcing the importance of resilient supply chains and validated clinical performance.

Key Country Insights for Wound Biologics

The United States is the largest strategic market, driven by chronic wound burden, specialized outpatient wound centers, and payer scrutiny around skin substitute utilization. Canada prioritizes evidence-based adoption within provincial systems, while Mexico and Brazil are expanding access through public-private healthcare investment, diabetes programs, and stronger hospital networks. In Europe, the United Kingdom, Germany, France, Italy, and Spain emphasize clinical value, hospital procurement discipline, health technology assessment, and aging-related wound needs, while Russia presents demand shaped by domestic access, reimbursement variation, and procurement constraints.

China and India represent high-growth opportunities due to large diabetes populations, rising surgical volumes, and increasing hospital capacity. Japan has strong need linked to population aging, advanced care standards, and demand for durable closure in chronic wounds. Australia supports steady uptake through specialist wound management, evidence-based reimbursement, and strong clinical governance, while South Korea combines sophisticated medical technology adoption, advanced hospital infrastructure, and export-oriented healthcare innovation to support the adoption of biologic wound care solutions.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical evidence that demonstrates faster healing, durable closure, fewer complications, and lower total cost of care. Randomized controlled trials, real-world evidence, and registry-based outcomes should be aligned with payer requirements for diabetic foot ulcers, venous leg ulcers, pressure injuries, burns, and surgical wounds. Companies should also invest in provider education that integrates biologics with debridement, infection control, offloading, compression, vascular assessment, nutrition, and glycemic control.

Commercial teams should segment markets by reimbursement maturity, wound center density, specialist availability, regulatory complexity, and clinical documentation requirements. Manufacturers can strengthen resilience by improving donor tissue sourcing, quality controls, cold-chain or shelf-stable logistics, and post-market surveillance. AI-enabled wound measurement, documentation, and patient selection tools should be adopted where they improve workflow, compliance, and measurable outcomes.

Research Methodology

The research methodology combines secondary research, expert validation, and data triangulation. Sources include regulatory documents, clinical guidelines, hospital procurement indicators, peer-reviewed wound care literature, reimbursement policies, public health datasets, and disease burden statistics from recognized organizations such as WHO, CDC, IDF, FDA, EMA, and national health agencies.

Market interpretation is developed through cross-verification of demand drivers, product adoption trends, regional access conditions, and competitive positioning. Insights are assessed by wound type, care setting, biologic category, evidence strength, reimbursement environment, regulatory status, and healthcare infrastructure. This approach supports an objective, data-backed executive view without relying on unverified claims, market sizing, or unsupported market assumptions.

Conclusion

Wound biologics are moving from a niche advanced wound care category to a core component of regenerative medicine and chronic wound management. The strongest opportunities are emerging where clinical evidence, reimbursement alignment, and specialist care pathways converge. Diabetes, aging populations, surgical complexity, burns, vascular disease, and pressure injury prevention will continue to sustain demand.

Future competitiveness will depend on differentiated biologic mechanisms, high-quality clinical data, scalable manufacturing, regulatory discipline, and digital integration. Organizations that combine proven wound healing outcomes with AI-enabled assessment, cost-effectiveness evidence, and region-specific access strategies will be best positioned to lead the global wound biologics market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Wound Biologics Market, by Product Type

  • 7.1. Collagen
    • 7.1.1. Bovine Collagen
    • 7.1.2. Equine Collagen
    • 7.1.3. Porcine Collagen
  • 7.2. Growth Factors
    • 7.2.1. Epidermal Growth Factor
    • 7.2.2. Fibroblast Growth Factor
    • 7.2.3. Platelet Derived Growth Factor
    • 7.2.4. Vascular Endothelial Growth Factor
  • 7.3. Platelet Derivatives
    • 7.3.1. Platelet Rich Fibrin
    • 7.3.2. Platelet Rich Plasma
  • 7.4. Skin Substitutes
    • 7.4.1. Biological Dermal
    • 7.4.2. Composite Dermal
    • 7.4.3. Synthetic Dermal

8. Wound Biologics Market, by Application

  • 8.1. Acute Wounds
  • 8.2. Burns
    • 8.2.1. Second Degree Burns
    • 8.2.2. Third Degree Burns
  • 8.3. Chronic Wounds
    • 8.3.1. Diabetic Foot Ulcer
    • 8.3.2. Pressure Ulcer
    • 8.3.3. Venous Leg Ulcer
  • 8.4. Surgical Wounds

9. Wound Biologics Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Home Care
  • 9.3. Hospitals
  • 9.4. Wound Care Centers

10. Wound Biologics Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Wound Biologics Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Wound Biologics Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Wound Biologics Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Acera Surgical, Inc.
  • 15.2. Alliqua BioMedical, Inc.
  • 15.3. Amnio Technology, LLC
  • 15.4. Anika Therapeutics, Inc.
  • 15.5. Aroa Biosurgery Limited
  • 15.6. Avita Medical, Inc.
  • 15.7. Aziyo Biologics, Inc.
  • 15.8. BioTissue, Inc.
  • 15.9. CollPlant Biotechnologies Ltd.
  • 15.10. Coloplast A/S
  • 15.11. Convatec Group Plc
  • 15.12. Fibroheal Woundcare Pvt Ltd
  • 15.13. Human BioSciences, Inc.
  • 15.14. Imbed Biosciences Inc.
  • 15.15. Integra LifeSciences Corporation
  • 15.16. Marine Polymer Technologies, Inc.
  • 15.17. MiMedx Group, Inc.
  • 15.18. MTF Biologics
  • 15.19. Organogenesis Inc.
  • 15.20. Osiris Therapeutics, Inc.
  • 15.21. Polynovo Limited
  • 15.22. RenovaCare, Inc.
  • 15.23. Skye Biologics, Inc.
  • 15.24. Smith & Nephew plc
  • 15.25. Solsys Medical LLC
  • 15.26. Tides Medical
  • 15.27. Vericel Corporation
  • 15.28. VIVEX Biologics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL WOUND BIOLOGICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL WOUND BIOLOGICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL WOUND BIOLOGICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL WOUND BIOLOGICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COLLAGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLLAGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLLAGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BOVINE COLLAGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BOVINE COLLAGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BOVINE COLLAGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EQUINE COLLAGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EQUINE COLLAGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EQUINE COLLAGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PORCINE COLLAGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PORCINE COLLAGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PORCINE COLLAGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GROWTH FACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EPIDERMAL GROWTH FACTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EPIDERMAL GROWTH FACTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EPIDERMAL GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FIBROBLAST GROWTH FACTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FIBROBLAST GROWTH FACTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FIBROBLAST GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLATELET DERIVED GROWTH FACTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLATELET DERIVED GROWTH FACTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PLATELET DERIVED GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR ENDOTHELIAL GROWTH FACTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR ENDOTHELIAL GROWTH FACTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR ENDOTHELIAL GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PLATELET DERIVATIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLATELET DERIVATIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PLATELET DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLATELET RICH FIBRIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PLATELET RICH FIBRIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLATELET RICH FIBRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL DERMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL DERMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL DERMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPOSITE DERMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COMPOSITE DERMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPOSITE DERMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SYNTHETIC DERMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SYNTHETIC DERMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SYNTHETIC DERMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE WOUNDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE WOUNDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE WOUNDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BURNS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BURNS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BURNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SECOND DEGREE BURNS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SECOND DEGREE BURNS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SECOND DEGREE BURNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL THIRD DEGREE BURNS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL THIRD DEGREE BURNS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL THIRD DEGREE BURNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CHRONIC WOUNDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CHRONIC WOUNDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CHRONIC WOUNDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIABETIC FOOT ULCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIABETIC FOOT ULCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIABETIC FOOT ULCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PRESSURE ULCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PRESSURE ULCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PRESSURE ULCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VENOUS LEG ULCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VENOUS LEG ULCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VENOUS LEG ULCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL WOUNDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL WOUNDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL WOUNDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL WOUND CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL WOUND CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL WOUND CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 181. GCC WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 183. GCC WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 184. GCC WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. GCC WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 187. GCC WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GCC WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 214. G7 WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 216. G7 WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 217. G7 WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. G7 WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 219. G7 WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 220. G7 WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. G7 WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. NATO WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 225. NATO WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 227. NATO WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 228. NATO WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. NATO WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 230. NATO WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. NATO WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 320. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. ITALY WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 340. SPAIN WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 341. SPAIN WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 342. SPAIN WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. SPAIN WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 344. CHINA WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 352. CHINA WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 353. CHINA WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 354. CHINA WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 355. INDIA WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 356. INDIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 357. INDIA WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 358. INDIA WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 359. INDIA WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 360. INDIA WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 361. INDIA WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 362. INDIA WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 363. INDIA WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 364. INDIA WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 365. INDIA WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 366. JAPAN WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 367. JAPAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 368. JAPAN WOUND BIOLOGICS MARKET SIZE, BY COLLAGEN, 2018-2032 (USD MILLION)
  • TABLE 369. JAPAN WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2032 (USD MILLION)
  • TABLE 370. JAPAN WOUND BIOLOGICS MARKET SIZE, BY PLATELET DERIVATIVES, 2018-2032 (USD MILLION)
  • TABLE 371. JAPAN WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 372. JAPAN WOUND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 373. JAPAN WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2032 (USD MILLION)
  • TABLE 374. JAPAN WOUND BIOLOGICS MARKET SIZE, BY CHRONIC WOUNDS, 2018-2032 (USD MILLION)
  • TABLE 375. JAPAN WOUND BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 376. JAPAN WOUND BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 377. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 378. AUSTRALIA W